Pfizer Inc (PFE)
25.98
+0.60
(+2.34%)
USD |
NYSE |
Apr 19, 16:00
25.90
-0.08
(-0.33%)
After-Hours: 19:07
Pfizer Debt to Equity Ratio: 0.7959 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.7959 |
| September 30, 2023 | 0.6561 |
| June 30, 2023 | 0.6599 |
| March 31, 2023 | 0.3459 |
| December 31, 2022 | 0.3644 |
| September 30, 2022 | 0.3852 |
| June 30, 2022 | 0.4487 |
| March 31, 2022 | 0.4253 |
| December 31, 2021 | 0.4792 |
| September 30, 2021 | 0.5074 |
| June 30, 2021 | 0.5387 |
| March 31, 2021 | 0.5565 |
| December 31, 2020 | 0.6052 |
| September 30, 2020 | 0.9428 |
| June 30, 2020 | 0.9887 |
| March 31, 2020 | 0.8041 |
| December 31, 2019 | 0.8052 |
| September 30, 2019 | 0.8088 |
| June 30, 2019 | 0.7835 |
| March 31, 2019 | 0.7677 |
| December 31, 2018 | 0.6584 |
| September 30, 2018 | 0.6791 |
| June 30, 2018 | 0.5807 |
| March 31, 2018 | 0.5818 |
| December 31, 2017 | 0.5975 |
| Date | Value |
|---|---|
| September 30, 2017 | 0.7232 |
| June 30, 2017 | 0.7488 |
| March 31, 2017 | 0.7531 |
| December 31, 2016 | 0.6896 |
| September 30, 2016 | 0.6961 |
| June 30, 2016 | 0.7039 |
| March 31, 2016 | 0.6242 |
| December 31, 2015 | 0.601 |
| September 30, 2015 | 0.582 |
| June 30, 2015 | 0.5251 |
| March 31, 2015 | 0.5338 |
| December 31, 2014 | 0.5145 |
| September 30, 2014 | 0.4751 |
| June 30, 2014 | 0.4936 |
| March 31, 2014 | 0.4754 |
| December 31, 2013 | 0.4782 |
| September 30, 2013 | 0.4688 |
| June 30, 2013 | 0.4678 |
| March 31, 2013 | 0.4909 |
| December 31, 2012 | 0.461 |
| September 30, 2012 | 0.4756 |
| June 30, 2012 | 0.4849 |
| March 31, 2012 | 0.4693 |
| December 31, 2011 | 0.4738 |
| September 30, 2011 | 0.4557 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.3459
Minimum
Mar 2023
0.9887
Maximum
Jun 2020
0.6264
Average
0.6052
Median
Dec 2020
Debt to Equity Ratio Benchmarks
| Amgen Inc | 10.37 |
| Gilead Sciences Inc | 1.094 |
| Johnson & Johnson | 0.4265 |
| Viking Therapeutics Inc | -- |
| Moderna Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 226.50B |
| Total Liabilities (Quarterly) | 137.21B |
| Shareholders Equity (Quarterly) | 89.01B |
| Current Ratio | 0.9067 |
| Net Debt Paydown Yield | -4.33% |